Relationship of XIST expression and responses of ovarian cancer to chemotherapy

Molecular Cancer Therapeutics

Volumn 1, Issue 10, 2002, Pages 769-776

  Huang, Kuan Chun ^a   Rao, Pulivarthi H ^b   Lau, Ching C ^b   Heard, Edith ^c   Ng, Shu Kay ^d   Brown, Carolyn ^e   Mok, Samuel C ^a   Berkowitz, Ross S ^a   Ng, Shu Wing ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c INSTITUT CURIE   (France)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; MESSENGER RNA; PACLITAXEL; RNA; TRANSCRIPTION FACTOR; UNTRANSLATED RNA; X (INACTIVE) SPECIFIC TRANSCRIPT (XIST); X (INACTIVE)-SPECIFIC TRANSCRIPT (XIST);

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHROMOSOME PAINTING; DNA MICROARRAY; DOWN REGULATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETIC MARKER; HUMAN; IC 50; METABOLISM; OVARY TUMOR; POLYADENYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL MODEL; TIME; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMOSOME PAINTING; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INHIBITORY CONCENTRATION 50; LINEAR MODELS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PACLITAXEL; POLYADENYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; RNA, UNTRANSLATED; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0036691881     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. du Bois, A., Neijt, J. P., and Thigpen, J. T. First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer - a new standard of care? Ann. Oncol., 10: 35-41, 1999.
2. Cannistra, S. A. Cancer of the ovary. N. Engl. J. Med., 329: 1550-1559, 1993. (Pubitemid 23332443)
3. Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J. C., Lashkari, D., Shalon, D., Myers, T. G., Weinstein, J. N., Botstein, D., and Brown, P. O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet., 24: 227-235, 2000. (Pubitemid 30132189)
4. Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., Scudiero, D. A., Eisen, M. B., Sausville, E. A., Pommier, Y., Botstein, D., Brown, P. O., and Weinstein, J. N. A gene expression database for the molecular pharmacology of cancer. Nat. Genet., 24: 236-244, 2000. (Pubitemid 30132190)
5. van't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-636, 2002.
6. Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., Lander, E. S., Loda, M., Kantoff, P. W., Golub, T. R., and Sellers, W. R. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell, 1: 203-209, 2002. (Pubitemid 41039166)
7. Yeoh, E-J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., Behm, F. G., Raimondi, S. C., Reilling, M. V., Patel, A., Cheng, C., Campana, D., Wilkins, D., Zhou, X., Li, J., Liu, H., Pui, C-H., Evans, W. E., Naeve, C., Wong, L., and Downing, J. R. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1: 133-143, 2002. (Pubitemid 41039160)
8. Riggs, A. D., and Pfeifer, G. P. X-chromosome inactivation and cell memory. Trends Genet., 8: 169-174, 1992.
9. Rastan, S., and Brown, S. D. The search for the mouse X-chromosome inactivation centre. Genet. Res., 56: 99-106, 1990.
10. Heard, E., Clerc, P., and Avner, P. X-chromosome inactivation in mammals. Annu. Rev. Genet., 31: 571-610, 1997. (Pubitemid 28023720)
11. Brown, C. J., Hendrich, B. D., Rupert, J. L., Lafreniere, R. G., Xing, Y., Lawrence, J., and Willard, H. F. The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell, 71: 527-542, 1992.
12. Panning, B., Dausman, J., and Jaenisch, R. X chromosome inactivation is mediated by Xist RNA stabilization. Cell, 90: 907-916, 1997. (Pubitemid 27381629)
13. Marahrens, Y., Panning, B., Dausman, J., Strauss, W., and Jaenisch, R. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev., 11: 156-166, 1997. (Pubitemid 27081893)
14. Penny, G. D., Kay, G. F., Sheardown, S. A., Rastan, S., and Brockdorff, N. Requirement for Xist in X chromosome inactivation. Nature (Lond.), 379: 131-137, 1996. (Pubitemid 26020194)
15. Heard, E., Mongelard, F., Arnaud, D., Chureau, C., Vourc'h, C., and Avner, P. Human XIST yeast artificial chromosome transgenes show partial X inactivation center function in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA, 96: 6841-6846, 1999. (Pubitemid 29274971)
16. Migeon, B. R., Luo, S., Stasiowski, B. A., Jani, M., Axelman, J., Van Dyke, D. L., Weiss, L., Jacobs, P. A., Yang-Feng, T. L., and Wiley, J. E. Deficient transcription of XIST from tiny ring X chromosomes in females with severe phenotypes. Proc. Natl. Acad. Sci. USA, 90: 12025-12029, 1993. (Pubitemid 24008773)
17. Efron, B. The Jackknife, the Bootstrap, and Other Resampling Plans, pp. 27-36. Philadelphia: SIAM, 1982.
18. Keohane, A. M., Barlow, A. L., Waters, J., Bourn, D., and Turner, B. M. H4 acetylation, XIST RNA and replication timing are coincident and define x;autosome boundaries in two abnormal X chromosomes. Hum. Mol. Genet., 8: 377-383, 1999. (Pubitemid 29054282)
19. Migeon, B. R., Kazi, E., Haisley-Royster, C., Hu, J., Reeves, R., Call, L., Lawler, A., Moore, C. S., Morrison, H., and Jeppesen, P. Human X inactivation center induces random X chromosome inactivation in male transgenic mice. Genomics, 59: 113-121, 1999. (Pubitemid 29365341)
20. Brown, C. J., and Willard, H. F. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature (Lond.), 368: 154-156, 1994.
21. Rack, K. A., Chelly, J., Gibbons, R. J., Rider, S., Benjamin, D., Lafreniere, R. G., Oscier, D., Hendriks, R. W., Craig, I. W., Willard, H. F., et al. Absence of the XIST gene from late-replicating isodicentric X chromosomes in leukaemia. Hum. Mol. Genet., 3: 1053-1059, 1994. (Pubitemid 24211947)
22. Csankovszki, G., Nagy, A., and Jaenisch, R. Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J. Cell Biol., 153: 773-784, 2001.
23. Deveraux, Q. L., and Reed, J. C. IAP family proteins - suppressors of apoptosis. Genes Dev., 13: 239-252, 1999. (Pubitemid 29095796)
24. Sasaki, H., Sheng, Y., Kotsuji, F., and Tsang, B. K. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res., 60: 5659-5666, 2000.
25. Cheng, P. C., Gosewehr, J. A., Kim, T. M., Velicescu, M., Wan, M., Zheng, J., Felix, J. C., Cofer, K. F., Luo, P., Biela, B. H., Godorov, G., and Dubeau, L. Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J. Natl. Cancer Inst., 88: 510-518, 1996. (Pubitemid 26118721)
26. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980. (Pubitemid 10073801)
27. Blagosklonny, M. V., and Fojo, T. Molecular effects of paclitaxel: myths and reality (a critical review). Int. J. Cancer, 83: 151-156, 1999. (Pubitemid 29449089)
28. Huang, T. S., Shu, C. H., Chao, Y., and Chen, L. T. Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosis. Anticancer Drugs, 12: 259-266, 2001. (Pubitemid 32269922)
29. Chen, R. H., Waters, J. C., Salmon, E. D., and Murray, A. W. Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores. Science (Wash. DC), 274: 242-246, 1996. (Pubitemid 26353200)